DAC Trials 2021
DOI: 10.48060/tghn.2
|View full text |Cite
|
Sign up to set email alerts
|

DAC Target Policy Profile (TPoP)

Abstract: In many cases, the end goal of clinical research is a change in policy, but there is often a gap between the research and policy sides, which can lead to wasted money and time. To address this, the Target Policy Profile (TPoP) has been developed for use both prior to research to identify key research questions to support policy decisions and at the point of evidence generation and dissemination. It is envisaged that the TPoP could help researchers analyze the evidence underlying a given policy, the gaps in tha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 26 publications
0
4
0
Order By: Relevance
“…We sorted the evidence descriptions identified from the review into broad groupings informed by the WHO 2017 guidelines for preventative chemotherapy for STH and a prior TPoP developed for other initiatives (17,19). These groupings were henceforth referred to as "evidence categories".…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…We sorted the evidence descriptions identified from the review into broad groupings informed by the WHO 2017 guidelines for preventative chemotherapy for STH and a prior TPoP developed for other initiatives (17,19). These groupings were henceforth referred to as "evidence categories".…”
Section: Methodsmentioning
confidence: 99%
“…A similar initiative was undertaken to identify vaccine-related evidence anticipated to facilitate global policy recommendations (28). The Evidence Considerations for Vaccine Policy (ECVP) initiative, based on a tool developed by the Bill & Melinda Gates Foundation called the Target Policy Profile, developed a tool to identify the anticipated clinical trial and observational data or evidence that could support WHO and/or policy decision making for new vaccines (17). Like the ECVP, the STH TPoP does not preclude or supersede independent guideline convenings or GRADE-based recommendations.…”
Section: Sth Stakeholders Generally Endorse More Detailed Information...mentioning
confidence: 99%
See 1 more Smart Citation
“…While the term was first mentioned in 2017, no package of attributes or sections was published at the time. In 2020, the TPoP was released publicly (Dolley, et al 2020). In 2021, the WHO was introduced to the tool, and used it as a basis for their Evidence Considerations for Vaccine Policy (Kochhar, et al 2022).…”
Section: Background: the Target Policy Profilementioning
confidence: 99%